@TDA and Kosenar. You are 100% correct I'm over reacting here, but recently find myself uncharacteristically impatient with the management of Biotechs, particularly as I have worked in Big Pharma
However as much as I would like to have faith in this management something is just not right - I'm happy to stand corrected on regulatory situation but re comments on launching version 1, generating cash flow and then working on Version 2 I'm steadfast.
Is the reason TIS has yet to land the BIG deal because such partners anticipated regulatory issues? I can only speculate, but one thing is for sure with such a unique and outstanding product in a burgeoning therapeutic area failing the find a BIG Pharma partner poses many questions.
TIS Price at posting:
43.5¢ Sentiment: Hold Disclosure: Held
